BioLASCO Taiwan , Ltd. Profit Margin

BioLASCO Taiwan , Ltd. (6662.TWO) currently reports a profit margin of 15.85% as of June 2026. That compares with 17.24% in the prior-year period — down 8.1% year over year. That is above the Healthcare sector average of 10.58%. Use the charts on this page to explore BioLASCO Taiwan , Ltd.'s profit margin history and peer comparisons.

BioLASCO Taiwan , Ltd.'s profit margin decreased from 17.24% to 15.85% — a 8.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioLASCO Taiwan , Ltd.'s profit margin of 15.85% is higher than the Healthcare sector average of 10.58%. That is roughly 49.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but BioLASCO Taiwan , Ltd.'s current 15.85% should be judged against Healthcare norms (sector average: 10.58%) and against 6662.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 15.85%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for BioLASCO Taiwan , Ltd., and consider following 6662.TWO for alerts when major investors trade the stock.